טוען...
Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.
Ceftazidime has pharmacokinetic advantages for treatment of endophthalmitis caused by gram negative-organisms by intravenous administration. Additionally, its spectrum of coverage for these organisms and its relatively low toxicity after intraocular injection are favorable attributes. These studies...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
1993
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1298483/ https://ncbi.nlm.nih.gov/pubmed/8140706 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|